INLYTA

AXITINIB · U.S. Pharmaceuticals

Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for INLYTA, covering 2012-01-27 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus [Phase 2]